Bibliographie (2530)
Yes, relapses after Paxlovid happen — now what?
mardi, 26 avril 2022 11:49 Écrit par Zouhair SouissiYes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations Commentary on Twitter Some additional thoughts about relapsing Covid19 after treatment with Paxlovid. Bottom line — *lots* of unknowns, starting w/ how often it happens. Looking forward to @pfizer sharing further data on the relapsing cases from their EPIC-HR study. https://t.co/1MMhqn4elw — […]
The post Yes, relapses after Paxlovid happen — now what? appeared first on Links Medicus.
Persistent COVID-19 symptoms in a community study of 606,434 people in England.
mardi, 26 avril 2022 11:49 Écrit par Zouhair SouissiPersistent COVID-19 symptoms in a community study of 606,434 people in England – Nature Communications Commentary on Twitter Thirty-eight percent of participants from a community-based study of symptoms following COVID-19 reported persistent symptoms that lasted 12 weeks or more, according to an article published in @NatureComms. https://t.co/sAEutdOkSS pic.twitter.com/oCyyXGIRbk — Nature Portfolio (@NaturePortfolio) April 20, […]
The post Persistent COVID-19 symptoms in a community study of 606,434 people in England. appeared first on Links Medicus.
Covid-19: Only a quarter of patients admitted to hospital feel fully recovered after a year, study finds.
mardi, 26 avril 2022 11:49 Écrit par Zouhair SouissiCovid-19: Only a quarter of patients admitted to hospital feel fully recovered after a year, study finds – The BMJ Original Study: Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study – The Lancet Respiratory Medicine Invited Commentary: Long COVID: systemic inflammation […]
The post Covid-19: Only a quarter of patients admitted to hospital feel fully recovered after a year, study finds. appeared first on Links Medicus.
Point/Counterpoint: Should asymptomatic OSA be treated in patients with significant cardiovascular disease?
lundi, 25 avril 2022 05:51 Écrit par Zouhair SouissiPOINT: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? Yes – CHEST COUNTERPOINT: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? No – CHEST
The post Point/Counterpoint: Should asymptomatic OSA be treated in patients with significant cardiovascular disease? appeared first on Links Medicus.
RCT: Segmentectomy resulted in better outcomes than lobectomy in small-sized peripheral non-small-cell lung cancer.
lundi, 25 avril 2022 05:51 Écrit par Zouhair SouissiSegmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
The post RCT: Segmentectomy resulted in better outcomes than lobectomy in small-sized peripheral non-small-cell lung cancer. appeared first on Links Medicus.
Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study.
lundi, 25 avril 2022 05:51 Écrit par Zouhair SouissiEchocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study) – Intensive Care Medicine Commentary on Twitter Echocardiography in #COVID19 #ICU pts, ECHO-COVID study ♥︎ systolic dysfunction in ⅓: 23% LV (similar to septic cardiomyopathy), 22.5% RV (due to P overload)♥︎ ACP in 17% (due to hypercapnia, […]
The post Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study. appeared first on Links Medicus.
One-year follow-up of a RCT: In ICU patients with severe hypoxemia, there was no difference in long-term mortality and health-related quality of life with lower vs. higher oxygenation targets.
vendredi, 22 avril 2022 13:09 Écrit par Zouhair SouissiLong-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia – Intensive Care Medicine Original Study: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure – New England Journal of Medicine Commentary on Twitter Lower (8 kPa) vs higher oxygenation (12 kPa) targets: no […]
The post One-year follow-up of a RCT: In ICU patients with severe hypoxemia, there was no difference in long-term mortality and health-related quality of life with lower vs. higher oxygenation targets. appeared first on Links Medicus.
WHO recommends highly successful COVID-19 therapy (nirmatrelvir-ritonavir) and calls for wide geographical distribution and transparency from originator.
vendredi, 22 avril 2022 13:09 Écrit par Zouhair SouissiWHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization See also: A living WHO guideline on drugs for covid-19 – The BMJ Therapeutics and COVID-19: living guideline – World Health Organization Related: Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal […]
The post WHO recommends highly successful COVID-19 therapy (nirmatrelvir-ritonavir) and calls for wide geographical distribution and transparency from originator. appeared first on Links Medicus.
RCT: Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for prevention of Covid-19.
jeudi, 21 avril 2022 14:00 Écrit par Zouhair SouissiIntramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 – New England Journal of Medicine Commentary on Twitter AZD7442 (tixagevimab/cilgavimab) found to have about 76% efficacy in preventing symptomatic Covid-19 infection. https://t.co/8tmvz3xI4I pic.twitter.com/fOegZjBRA6 — NEJM (@NEJM) April 20, 2022
The post RCT: Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for prevention of Covid-19. appeared first on Links Medicus.
Cohort study: COVID-19 infection granted patients strong and long-lasting protection from reinfection.
jeudi, 21 avril 2022 14:00 Écrit par Zouhair SouissiNews Release: COVID-19 infection granted patients strong and long-lasting protection from reinfection – Providence Health & Services Original Study: Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19 – JAMA Network Open Commentary: COVID-19 infection may offer similar immunity as vaccination – CIDRAP Commentary on Twitter This US cohort study found that unvaccinated individuals […]
The post Cohort study: COVID-19 infection granted patients strong and long-lasting protection from reinfection. appeared first on Links Medicus.
